Wall Street brokerages expect National Health Investors Inc (NYSE:NHI) to announce $1.42 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for National Health Investors’ earnings, with the lowest EPS estimate coming in at $1.39 and the highest estimate coming in at $1.45. National Health Investors reported earnings per share of $1.36 during the same quarter last year, which suggests a positive year over year growth rate of 4.4%. The company is scheduled to report its next quarterly earnings results on Thursday, August 13th.
On average, analysts expect that National Health Investors will report full year earnings of $5.59 per share for the current fiscal year, with EPS estimates ranging from $5.54 to $5.64. For the next year, analysts anticipate that the company will post earnings of $5.55 per share, with EPS estimates ranging from $5.35 to $5.70. Zacks’ EPS calculations are a mean average based on a survey of sell-side research firms that follow National Health Investors.
National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Monday, May 11th. The real estate investment trust reported $1.37 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.40 by ($0.03). The company had revenue of $83.08 million during the quarter, compared to the consensus estimate of $80.77 million. National Health Investors had a net margin of 57.16% and a return on equity of 12.62%. National Health Investors’s revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.31 EPS.
Several equities research analysts recently issued reports on the stock. SunTrust Banks cut their target price on shares of National Health Investors from $77.00 to $61.00 and set a “hold” rating for the company in a research note on Thursday, April 23rd. Wells Fargo & Co cut their target price on shares of National Health Investors from $82.00 to $51.00 and set an “equal weight” rating for the company in a research note on Thursday, March 26th. Berenberg Bank assumed coverage on shares of National Health Investors in a research note on Wednesday, February 5th. They issued a “buy” rating and a $94.00 target price for the company. Mizuho downgraded shares of National Health Investors from a “buy” rating to a “neutral” rating and cut their target price for the company from $60.00 to $55.00 in a research note on Friday. Finally, KeyCorp cut their target price on shares of National Health Investors from $43.00 to $40.00 and set an “underweight” rating for the company in a research note on Thursday, May 14th. Three investment analysts have rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $67.57.
In related news, Director Robert T. Webb acquired 2,151 shares of the business’s stock in a transaction on Monday, March 16th. The stock was purchased at an average cost of $46.28 per share, for a total transaction of $99,548.28. Following the completion of the transaction, the director now directly owns 63,339 shares of the company’s stock, valued at approximately $2,931,328.92. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO D. Eric Mendelsohn sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $90.58, for a total transaction of $362,320.00. Following the sale, the chief executive officer now owns 44,256 shares of the company’s stock, valued at $4,008,708.48. The disclosure for this sale can be found here. Insiders have acquired 29,576 shares of company stock valued at $1,096,421 over the last 90 days. Company insiders own 5.74% of the company’s stock.
A number of hedge funds have recently modified their holdings of NHI. ERTS Wealth Advisors LLC acquired a new stake in National Health Investors during the fourth quarter worth approximately $25,000. Van ECK Associates Corp raised its position in shares of National Health Investors by 108.4% in the first quarter. Van ECK Associates Corp now owns 521 shares of the real estate investment trust’s stock valued at $26,000 after buying an additional 271 shares in the last quarter. Marshall Wace North America L.P. acquired a new stake in shares of National Health Investors in the first quarter valued at approximately $31,000. Samalin Investment Counsel LLC acquired a new stake in shares of National Health Investors in the fourth quarter valued at approximately $40,000. Finally, Duncker Streett & Co. Inc. acquired a new stake in shares of National Health Investors in the fourth quarter valued at approximately $46,000. Hedge funds and other institutional investors own 70.53% of the company’s stock.
Shares of NYSE NHI opened at $52.98 on Monday. The stock has a market capitalization of $2.41 billion, a price-to-earnings ratio of 9.71 and a beta of 0.85. The business has a 50-day moving average of $50.81 and a 200-day moving average of $71.49. The company has a debt-to-equity ratio of 1.03, a current ratio of 12.05 and a quick ratio of 12.05. National Health Investors has a fifty-two week low of $31.37 and a fifty-two week high of $91.12.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Featured Story: What is the return on assets formula?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.